Table of Contents:
1 Report Prologue
2 Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing prevalence of Sports Injuries
4.1.2 Increasing number of Sports Medicine Associations
4.1.3 Increasing Awareness
4.1.4 Technological development
4.2 Restraints
4.2.1 Lack of skilled professionals
4.2.2 High cost
4.3 Opportunities
4.3.1 Rise in influx of athletes
4.3.2 Technological advances in sports medicines
4.4 Threats
4.4.1 Introduction of small and medium sized companies
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
6 Global Sports Medicine Market, By Product
6.1 Introduction
6.1.1 Joint Reconstructive & Repair Products
6.1.2 Body Support and recovery products
6.1.3 Accessories
7 Global Sports Medicines Market, By Application
7.1 Introduction
7.1.1 Shoulder Treatment
7.1.2 Knee Treatment
7.1.3 Hip Treatment
7.1.4 Spine Treatment
8 Global Sports Medicines Market, by Procedures
8.1 Introduction
8.1.1 Tendinosis
8.1.2 Tendon to Bone
8.1.3 Cartilage repair
9 Global Sports Medicines Market, By End User
9.1 Introduction
9.1.1 Hospital & Emergency Care
9.1.2 Trauma center
9.1.3 Ambulatory Care
10 Global Sports Medicine Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Introduction
10.2.2 U.S.
10.2.3 Canada
10.2.4 South America
10.3 Europe
10.3.1 Introduction
10.3.2 Germany
10.3.3 France
10.3.4 UK
10.3.5 Italy
10.3.6 Spain
10.3.7 Rest of Western Europe
10.3.8 Eastern Europe
10.4 Asia-Pacific
10.4.1 Introduction
10.4.2 Japan
10.4.3 China
10.4.4 India
10.4.5 Republic of Korea
10.4.6 Australia
10.4.7 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 Introduction
10.5.2 Middle East
10.5.3 Africa
11 Company Landscape
11.1 Introduction
12 Company Profile
12.1 Medtronics
12.1.1 Company Overview
12.1.2 Product/Business Segment Overview
12.1.3 Financial Overview
12.1.4 Key Development
12.2 Stryker
12.2.1 Company Overview
12.2.2 Product/Business Segment Overview
12.2.3 Financial Overview
12.2.4 Key Development
12.3 Zimmer Biomet
12.3.1 Company Overview
12.3.2 Product/Business Segment Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.4 Conmed Corporation
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.5 DePuy Synthes
12.5.1 Company Overview
12.5.2 Product/Business Segment Overview
12.5.3 Financial Overview
12.5.4 Key Development
12.6 GE Healthcare
12.6.1 Company Overview
12.6.2 Product/Business Segment Overview
12.6.3 Financial Overview
12.6.4 Key Development
12.7 Smith & Nephew plc
12.7.1 Company Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.8 Arthrex, Inc.
12.8.1 Company Overview
12.8.2 Product/Business Segment Overview
12.8.3 Financial Overview
12.8.4 Key Development